PerkinElmer to Present at J.P. Morgan 37th Annual Healthcare Conference
WALTHAM, Mass.--(BUSINESS WIRE)--Dec 21, 2018--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the J.P. Morgan 37 th Annual Healthcare Conference on Wednesday, January 9, 2019, at 10:00 a.m. PT at the Westin St. Francis Hotel in San Francisco.
Robert F. Friel, PerkinElmer’s chairman and chief executive officer, will provide an overview of the Company and its strategic priorities.
A live audio webcast of the presentation will also be available on the Investors section of the Company’s website at www.perkinelmer.com. A replay of the presentation will be posted on the PerkinElmer website after the event and will be available for two weeks following.
About PerkinElmer PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $2.3 billion in 2017, has about 11,000 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181221005020/en/
CONTACT: Investor Relations:
Tommy J. Thomas, 781-663-5889
Brian Willinsky, 781-663-5728
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA MASSACHUSETTS
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY MEDICAL DEVICES PHARMACEUTICAL GENERAL HEALTH
SOURCE: PerkinElmer, Inc.
Copyright Business Wire 2018.
PUB: 12/21/2018 04:15 PM/DISC: 12/21/2018 04:15 PM